1. Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes

   • Vincenzo Maria Monda
   • Sandro Gentile
   • Felice Strollo

   Editorial Open access 16 September 2022 Pages: 4837 - 4846

   

2. The Patient Matters in the End(point)

   • Pip Griffiths
   • Diana Rofail
   • Vera Mastey

   Commentary Open access 05 August 2022 Pages: 4847 - 4852

   

3. Correction to: The Patient Matters in the End(point)

   • Pip Griffiths
   • Diana Rofail
   • Vera Mastey

   Correction Open access 09 September 2022 Pages: 4853 - 4853

4. Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review

   • Carlos Patricio Acosta-Rodríguez-Bueno
   • Ana Teresa Abreu y Abreu
   • Marcos Perez III

   Review Open access 26 August 2022 Pages: 4854 - 4874

   

5. Risperidone ISM as a New Option in the Clinical Management of Schizophrenia: A Narrative Review

   • Cecilio Álamo

   Review Open access 01 September 2022 Pages: 4875 - 4891

   

6. Efficacy of Low-Dose Estrogen–Progestins and Progestins in Japanese Women with Dysmenorrhea: A Systematic Review and Network Meta-analysis

   • Masaru Iwata
   • Yoshihiro Oikawa
   • Yutaka Osuga

   Review Open access 01 September 2022 Pages: 4892 - 4909

   

7. A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19

   • Thomas Bieber
   • Eugen Feist
   • Peter C. Taylor

   Review Open access 05 September 2022 Pages: 4910 - 4960

   

8. Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis

   • Afisi S. Ismaila
   • Katrin Haeussler
   • David M. G. Halpin

   Original Research Open access 20 July 2022 Pages: 4961 - 5010

   

9. Correction to: Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis

   • Afisi S. Ismaila
   • Katrin Haeussler
   • David M. G. Halpin

   Correction Open access 02 September 2022 Pages: 5011 - 5012

   

10. Five-Year Estimated Glomerular Filtration Rate in Adults with Chronic Hypoparathyroidism Treated with rhPTH(1-84): A Retrospective Cohort Study

    • Olulade Ayodele
    • Lars Rejnmark
    • Elvira O. Gosmanova

    Original Research Open access 26 August 2022 Pages: 5013 - 5024

    

11. The Hospitalization-Related Costs of Adverse Events for Novel Androgen Receptor Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: An Indirect Comparison

    • Neal Shore
    • Shan Jiang
    • A. Reginald Waldeck

    Original Research Open access 26 August 2022 Pages: 5025 - 5042

    

12. The Effectiveness of Chemoradiotherapy in Elderly Patients with Pancreatic Cancer: A Population-Based Study Based on the SEER Database

    • Duorui Nie
    • Siyu Liu
    • Fei Xu

    Original Research 31 August 2022 Pages: 5043 - 5057

    

13. Septic Shock: Phenotypes and Outcomes

    • Alexandre Cereuil
    • Romain Ronflé
    • Marc Leone

    Original Research 01 September 2022 Pages: 5058 - 5071

    

14. The Patient and Clinician Assessment of Gastrointestinal (GI) Related Adverse Events Associated with Oral Disease-Modifying Therapies in Multiple Sclerosis: A Qualitative Study

    • Farah Jivraj
    • Sha Kang
    • Marvin Rock

    Original Research Open access 02 September 2022 Pages: 5072 - 5086

15. Quality of Life in Japanese Patients with Dysmenorrhea or Endometriosis-Associated Pelvic Pain Treated with Extended Regimen Ethinylestradiol/Drospirenone in a Real-World Setting: A Prospective Observational Study

    • Osamu Yoshino
    • Yoshimi Suzukamo
    • Noriko Takahashi

    Original Research Open access 02 September 2022 Pages: 5087 - 5104

    

16. Validation of the PRUCISION Instruments in Pediatric Patients with Progressive Familial Intrahepatic Cholestasis

    • Chad Gwaltney
    • Cristina Ivanescu
    • Patrick Horn

    Original Research Open access 06 September 2022 Pages: 5105 - 5125

    

17. Development of the Patient- and Observer-Reported PRUCISION Instruments to Assess Pruritus and Sleep Disturbance in Pediatric Patients with Cholestatic Liver Diseases

    • Chad Gwaltney
    • Stephanie Bean
    • Patrick Horn

    Original Research Open access 06 September 2022 Pages: 5126 - 5143

    

18. Safety, Tolerability, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder for Pulmonary Hypertension: A Phase 1, Randomized, Double-Blind, Single- and Multiple-Dose Study

    • Fraz A. Ismat
    • Helen H. Usansky
    • Ariel Teper

    Original Research Open access 07 September 2022 Pages: 5144 - 5157

    

19. Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease: A Multicenter, Open-Label, Prospective Study

    • Haruhito A. Uchida
    • Hirofumi Nakajima
    • the EX-DKD investigators

    Original Research Open access 07 September 2022 Pages: 5158 - 5175

    

20. Potential Unmet Needs in Acute Treatment of Migraine in Japan: Results of the OVERCOME (Japan) Study

    • Takao Takeshima
    • Kaname Ueda
    • Koichi Hirata

    Original Research Open access 12 September 2022 Pages: 5176 - 5190

    

21. Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers

    • Jeffrey E. Carter
    • Joshua S. Carson
    • Jeremiah A. Sparks

    Original Research Open access 14 September 2022 Pages: 5191 - 5202

    

22. Moderate Psoriasis in Clinical Practice: French Expert Consensus Using a Modified Delphi Method

    • Marie-Aleth Richard
    • François Aubin
    • Denis Jullien

    Original Research Open access 16 September 2022 Pages: 5203 - 5215

    

23. Experience on the Management of Patients with Asthma or Chronic Obstructive Pulmonary Disease During the COVID-19 Pandemic: the NEUMOBIAL Study

    • Pedro Landete
    • Jose Ignacio Prieto Romo
    • Fernando Giacomini

    Original Research Open access 17 September 2022 Pages: 5216 - 5228

    

24. Safety Findings in Lasmiditan as a Novel Acute Treatment of Migraine in Chinese Patients: A Post Hoc Analysis of the Randomized Controlled Phase 3 CENTURION Trial

    • Jiying Zhou
    • Guogang Luo
    • Shengyuan Yu

    Original Research 17 September 2022 Pages: 5229 - 5243

    

25. Nicotine Replacement Therapy for Smokers with Acute Aneurysmal Subarachnoid Hemorrhage: An International Survey

    • Christian V. Eisenring
    • Preci L. Hamilton
    • David Nanchen

    Original Research Open access 19 September 2022 Pages: 5244 - 5258

    

26. Post-switch Effectiveness of Etanercept Biosimilar Versus Continued Etanercept in Rheumatoid Arthritis Patients with Stable Disease: A Prospective Multinational Observational Study

    • Janet Pope
    • Stephen Hall
    • David Wu

    Original Research 22 September 2022 Pages: 5259 - 5273

    

27. Efficacy of Lasmiditan Across Patient and Migraine Characteristics in Japanese Patients with Migraine: A Secondary Analysis of the MONONOFU Trial

    • Takao Takeshima
    • Mika Komori
    • Yoshihisa Tatsuoka

    Original Research Open access 22 September 2022 Pages: 5274 - 5288

    

28. Recurrent Ovarian Cancer with BRCAness Phenotype: A Treatment Challenge

    • Cláudia Caeiro
    • Inês Leão
    • Teresa André

    Case Series Open access 05 September 2022 Pages: 5289 - 5299

    

29. Correction to: Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018

    • Yifei Liu
    • Martha Skup
    • Eric Q. Wu

    Correction Open access 30 August 2022 Pages: 5300 - 5300